Precision diagnostics, which uses genetic and cellular targeting to decide which drugs are best suited for individual patients, is dragging disease care out of the realm of guesswork.
The genetic revolution in biology is set to produce a steady flow of new drugs, diagnostics and medical devices to help meet the demand, while a prosperous economy will let people spend lavishly.